QA: BALCHEM CORP in us_medicinal_products/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000009326_2021_BALCHEM_CORP.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000009326, BALCHEM CORP

  xvar xval
0 LiabilitiesNoncurrent 0
1 LiabilitiesCurrent 145,787,000
2 remainder_Liabilities 191,823,000
3 AssetsCurrent 266,888,000
4 AssetsNoncurrent 11,326,000
5 PropertyPlantAndEquipmentNet 228,096,000
6 Goodwill 651,123,000
7 remainder_Assets 8,410,000
8 GeneralAndAdministrativeExpense 582,165,000
9 ResearchAndDevelopmentExpense 10,332,000
10 remainder_Expenses 21,794,000
11 remainder_Revenues 703,644,000
12 remainder_NetIncome -4,730,000
13 remainder_ComprehensiveNetIncome 9,737,000
  yvar yval
0 Liabilities 337,610,000
1 Assets 1,165,843,000
2 Expenses 614,291,000
3 Revenues 703,644,000
4 StockholdersEquity 828,233,000
5 NetIncome 84,623,000
6 ComprehensiveNetIncome 89,491,500
7 BaseVar 1,417,927,500
8 EconomicCapitalRatio 1.06

Edgar->Model Mapping

Feature Distribution

Change over Time